JCPyV VP1/LT-specific CD8 T cell adoptive immunotherapy in a PML patient drove viral DNA below PCR detectability in the CSF and improved neurological status [57]. This evidence concerns the gene CD8A and progressive multifocal leukoencephalopathy.